NFKBIA and Alzheimer disease: With regard to IκB-α, we observed significant differences between the patients (Figure 10, F (2, 20) = 5.466, p = 0.0128), finding an increased IκB-α immunoreactivity in the WE case compared with the control (p = 0.0462) and with the AD subject (p = 0.0207).